83 FR 6563 - Sunshine Act Meeting

FEDERAL ELECTION COMMISSION

Federal Register Volume 83, Issue 31 (February 14, 2018)

Page Range		6563-6563
FR Document		2018-03166

Federal Register, Volume 83 Issue 31 (Wednesday, February 14, 2018)

[Federal Register Volume 83, Number 31 (Wednesday, February 14, 2018)]
[Notices]
[Page 6563]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-03166]


=======================================================================
-----------------------------------------------------------------------

FEDERAL ELECTION COMMISSION


Sunshine Act Meeting

TIME AND DATE: Thursday, February 15, 2018 at 10:00 a.m.

PLACE: 999 E Street NW, Washington, DC (Ninth Floor).

STATUS: This Meeting, open to the public, has been cancelled.

CONTACT PERSON FOR MORE INFORMATION: Judith Ingram, Press Officer, 
Telephone: (202) 694-1220.


Signed:
Dayna C. Brown,
Secretary and Clerk of the Commission.
[FR Doc. 2018-03166 Filed 2-12-18; 4:15 pm]
 BILLING CODE 6715-01-P

Federal Register / Vol. 83, No. 31 / Wednesday, February 14, 2018 / Notices 6563

Wireless Telecommunications Bureau Signed: DEPARTMENT OF HEALTH AND
and Wireline Competition Bureau (the Dayna C. Brown, HUMAN SERVICES
Bureaus) may implement, and (3) certify Secretary and Clerk of the Commission.
its challenge. The USAC system will Centers for Disease Control and
[FR Doc. 2018–03166 Filed 2–12–18; 4:15 pm]
validate a challenger’s evidence using Prevention
BILLING CODE 6715–01–P
an automated challenge validation [CDC–2018–0004; NIOSH–233–B]
process. Once all valid challenges have
been identified, a challenged party that NIOSH List of Antineoplastic and Other
chooses to respond to any valid Hazardous Drugs in Healthcare
FEDERAL RESERVE SYSTEM
challenge(s) may submit additional data Settings: Proposed Additions to the
via the online USAC portal during the Change in Bank Control Notices; NIOSH Hazardous Drug List 2018
established response window. A Acquisitions of Shares of a Bank or
challenged party may submit technical AGENCY: Centers for Disease Control and
Bank Holding Company Prevention, HHS.
information that is probative regarding
the validity of a challenger’s speed tests, ACTION: Notice of draft document
The notificants listed below have
including speed test data and other available for public comment.
applied under the Change in Bank
device-specific data collected from
Control Act (12 U.S.C. 1817(j)) and SUMMARY: The National Institute for
transmitter monitoring software or,
§ 225.41 of the Board’s Regulation Y (12 Occupational Safety and Health
alternatively, may submit its own speed
test data that conforms to the same CFR 225.41) to acquire shares of a bank (NIOSH) of the Centers for Disease
standards and requirements specified by or bank holding company. The factors Control and Prevention (CDC)
the Commission and the Bureaus for that are considered in acting on the announces the availability for public
challengers. notices are set forth in paragraph 7 of comment on the drugs proposed for
the Act (12 U.S.C. 1817(j)(7)). placement on the NIOSH List of
In conjunction with the qualified 4G Antineoplastic and Other Hazardous
LTE data separately collected pursuant The notices are available for
Drugs in Healthcare Settings, 2018
to OMB 3060–1242 that will be used to immediate inspection at the Federal
(List), as well as the NIOSH Policy and
create the map of areas presumptively Reserve Bank indicated. The notices
Procedures for Developing the NIOSH
eligible for MF–II support, the also will be available for inspection at
List of Antineoplastic and Other
information collected under this MF–II the offices of the Board of Governors. Hazardous Drugs in Healthcare Settings.
challenge process collection will enable Interested persons may express their
DATES: Comments must be received by
the Commission to efficiently resolve views in writing to the Reserve Bank
disputes concerning the eligibility or April 16, 2018.
indicated for that notice or to the offices
ineligibility of an area initially deemed ADDRESSES: Comments may be
of the Board of Governors. Comments
ineligible for MF–II support and must be received not later than March submitted, identified by docket numbers
establish the final map of areas eligible CDC–2018–0004 and NIOSH–233–B, by
7, 2018.
for such support, thereby furthering the either of the following two methods:
Commission’s goal of targeting MF–II
A. Federal Reserve Bank of Atlanta • Federal eRulemaking Portal:
support to areas that lack adequate (Kathryn Haney, Director of www.regulations.gov. Follow the
mobile voice and broadband coverage Applications) 1000 Peachtree Street NE, instructions for submitting comments.
absent subsidies through a transparent Atlanta, Georgia 30309. Comments can • Mail: NIOSH Docket Office, Robert
process. also be sent electronically to A. Taft Laboratories, MS–C34, 1090
Applications.Comments@atl.frb.org: Tusculum Avenue, Cincinnati, OH
The Commission received approval
1. Brandt J. Dufrene, Sr., individually 45226–1998.
from OMB for the information collection
and as trustee for The FSC Trust No. 1, Instructions: All information received
requirements contained in OMB 3060–
and Brandt J. Dufrene, Jr., individually in response to this notice must include
1251 on February 7, 2018.
the agency name and the docket
Federal Communications Commission. and as the trustee for The FSC Trust No.
numbers (CDC–2018–0004; NIOSH–
2 and the Brandt J. Dufrene, Jr. Trust
Marlene H. Dortch, 233–B). All relevant comments received
No. 1, all of Metairie, Louisiana; to will be posted without change to
Secretary, Office of the Secretary.
retain voting shares of First St. Charles www.regulations.gov, including any
[FR Doc. 2018–03000 Filed 2–13–18; 8:45 am]
Bancshares, Inc., and thereby indirectly personal information provided.
BILLING CODE 6712–01–P
retain First National Bank USA, both
FOR FURTHER INFORMATION CONTACT:
Boutte, Louisiana.
Barbara MacKenzie, NIOSH, Robert A.
Board of Governors of the Federal Reserve Taft Laboratories, 1090 Tusculum
FEDERAL ELECTION COMMISSION System, February 9, 2018. Avenue, MS–C26, Cincinnati, OH
Ann E. Misback, 45226, telephone (513) 533–8132 (not a
Sunshine Act Meeting toll free number), Email:
Secretary of the Board.
[FR Doc. 2018–03082 Filed 2–13–18; 8:45 am] hazardousdrugs@cdc.gov.
TIME AND DATE: Thursday, February 15, SUPPLEMENTARY INFORMATION:
2018 at 10:00 a.m. BILLING CODE P
I. Public Participation
PLACE:999 E Street NW, Washington,
daltland on DSKBBV9HB2PROD with NOTICES

DC (Ninth Floor). Interested parties are invited to
participate in this action by submitting
STATUS: This Meeting, open to the written views, opinions,
public, has been cancelled. recommendation, and/or data.
CONTACT PERSON FOR MORE INFORMATION: Comments are invited on any topic
Judith Ingram, Press Officer, Telephone: related to the drugs identified in this
(202) 694–1220. notice, including those evaluated for

VerDate Sep<11>2014 22:07 Feb 13, 2018 Jkt 244001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\14FEN1.SGM 14FEN1

Document Created: 2018-02-14 03:58:59
Document Modified: 2018-02-14 03:58:59

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		Thursday, February 15, 2018 at 10:00 a.m.
FR Citation		83 FR 6563